Finally, we propose that silencing Mat1a in obesity activates NRF2 in hepatocytes and induces the secretion of FGF21 to the general circulation, which increases WAT lipolysis and BAT thermogenesis, decreasing de novo lipogenesis in the liver. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.